Komori
M&A and Subsidiary Changes9162Bleach,Inc.Information and Communications, Services and Others

Notice Regarding the Establishment of a Subsidiary

The Company has decided to establish 株式会社みのり自然食品 as a wholly owned subsidiary responsible for product planning and sales in the healthcare sector. The subsidiary is scheduled to be established and commence operations on 1 June 2026.

Worth reading
49Recurring
Scored from 3 of 5 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
1000
¥10,000 (planned)
Wording
Conditional
How definitive the wording is.

This transaction

Establishment of subsidiary
Disclosing companyBleach,Inc.
株式会社みのり自然食品Voting rights ownership percentage

The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.

TimelineThe spacing between the points is proportional to the actual number of days.White points represent dates designated as scheduled dates in the document.
Target company

Planning and sales of products in the healthcare sector

Location Meguro-ku, TokyoShare capital ¥10 million (planned)Date of incorporation 1 June 2026 (予定)
Impact on Business Performance

The impact of establishing this subsidiary on consolidated results for the fiscal year ending June 2026 is expected to be immaterial.

Procedures and assumptions
Management structure after acquisitionThe representative director and president will be Ohira Keisuke (大平啓介). Officers and employees of the Company are scheduled to concurrently serve as directors and other officers of the subsidiary. The Company is scheduled to provide certain business services to the subsidiary.
This transaction
ItemDetails
Transaction nameEstablishment of subsidiary
Name of the Subject Company株式会社みのり自然食品
Business Description of the Subject CompanyPlanning and sales of products in the healthcare sector
Location of the Subject CompanyMeguro-ku, Tokyo
Capital Stock of the Subject Company¥10 million (planned)
Date of Establishment of the Subject Company1 June 2026 (予定)
Voting rights ownership percentageAfter 100% (before not disclosed)
Impact on Business PerformanceThe impact of establishing this subsidiary on consolidated results for the fiscal year ending June 2026 is expected to be immaterial.
Date of board resolution22 May 2026
Execution Date / Effective Date1 June 2026 (予定)
Management structure after acquisitionThe representative director and president will be Ohira Keisuke (大平啓介). Officers and employees of the Company are scheduled to concurrently serve as directors and other officers of the subsidiary. The Company is scheduled to provide certain business services to the subsidiary.
Items this document does not state (21)
Counterparty nameNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Contract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to Execution

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The objective is to expand the business portfolio and establish a new earnings base. The Company plans to leverage its marketing capabilities, product planning expertise, consumer purchasing data and market analysis knowledge accumulated to date to develop and sell proprietary branded products, including health foods, thereby expanding its business domains and diversifying its sources of revenue.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Establishment of a Subsidiary | Bleach,Inc. (9162) timely disclosure | Komori